"If-then" conditional logic for protein drugs
SynsoryBio is creating next generation, protein therapeutics that sense where they are in the body and only activate at diseased tissue. This technology platform has the potential to expand the therapeutic window of highly potent drugs and apply to many diseases such as cancer and autoimmune disorders.
What they do:
Building programmable therapeutics for the immune system
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Genetically engineered viruses that teach your immune system to kill…
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Adventris makes cancer vaccines
Quick facts:
HQ: Baltimore, MD, United States
What they do:
Combinations therapy by rational design
Quick facts:
HQ: New York, NY, United States
What they do:
Elevated mRNA for transformative medicines.
Quick facts:
HQ: San Francisco, CA, United States
What they do:
Breakthrough medicines unlocking the biology of heme
Quick facts:
HQ: San Francisco, CA, United States
"If-then" conditional logic for protein drugs
Boston, MA, United States
2 employees, according to the company profile.
There are no funding rounds for SynsoryBio in our data.
Similar startups: Granza Bio, Kopra Bio, and Adventris Pharmaceuticals.